Literature DB >> 15155290

Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland.

M Artama1, J I T Isojärvi, J Raitanen, A Auvinen.   

Abstract

Few reports on population-based studies of birth rate among epilepsy patients have been published. In most previous studies, fertility has been lower among epilepsy patients than in the rest of the population. However, conflicting results have also been reported. Because of small samples and selective material, the generalizability of these results is also limited. The authors conducted a population-based cohort study of birth rate (1985-2001) in a nationwide Finnish cohort of patients with newly diagnosed epilepsy and a population-based reference cohort. All patients (n = 14,077) approved as eligible for reimbursement for antiepileptic medication from the Social Insurance Institution of Finland (KELA) for the first time between 1985 and 1994 were identified from the KELA database. A reference cohort (n = 29,828) was identified from the Finnish Population Register Center, with frequency-matching on age. Information on follow-up status and livebirths were also obtained from the Finnish Population Register Center. The birth rate was lower in patients with epilepsy than in the reference cohort among both men (hazard ratio = 0.58, 95% confidence interval: 0.54, 0.62) and women (hazard ratio = 0.88, 95% confidence interval: 0.83, 0.93). There were a clear decreasing trend by age at observation in men with epilepsy and a moderate decreasing trend by age at start of follow-up in women with epilepsy.

Entities:  

Mesh:

Year:  2004        PMID: 15155290     DOI: 10.1093/aje/kwh140

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  14 in total

1.  Women With Epilepsy and Control Women: Two Peas in a WEPOD.

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

Review 2.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

Review 3.  Management of epilepsy in women of childbearing age: practical recommendations.

Authors:  Barbara Tettenborn
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  [Neuropsychological outcome following intrauterine exposure to valproate].

Authors:  B Schmitz; G Krämer; C Helmstädter; H Jokeit; S Koch; G Luef; C Schaefer
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 5.  Managing epilepsy in women of childbearing age.

Authors:  Pamela M Crawford
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Hormonal aspects of epilepsy.

Authors:  Page B Pennell
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

Review 7.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

8.  Fertility and Birth Outcomes in Women With Epilepsy Seeking Pregnancy.

Authors:  Page B Pennell; Jacqueline A French; Cynthia L Harden; Anne Davis; Emilia Bagiella; Evie Andreopoulos; Connie Lau; Nichelle Llewellyn; Sarah Barnard; Stephanie Allien
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

9.  Reproductive decision-making in families containing multiple individuals with epilepsy.

Authors:  Jacquelyn Nakamura; Shawn T Sorge; Melodie R Winawer; Jo C Phelan; Wendy K Chung; Ruth Ottman
Journal:  Epilepsia       Date:  2021-04-04       Impact factor: 5.864

10.  Infertility treatment and umbilical cord length-novel markers of childhood epilepsy?

Authors:  Sari Räisänen; Arja Sokka; Leena Georgiadis; Maija Harju; Mika Gissler; Leea Keski-Nisula; Reetta Kälviäinen; Seppo Heinonen
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.